Postoperative nausea and vomiting after general anesthesia with Remimazolam.

Comparison of the effects of remimazolam, propofol, and inhalational agent on postoperative nausea and vomiting: a propensity score matching study.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-jRCT1041210079

Enrollment

5000

Registered

2021-10-05

Start date

2021-10-05

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

General anesthesia

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: All patients who had undergone surgery under general anesthesia at Hamamatsu University Hospital since August 2020.

Exclusion criteria

Exclusion criteria: less than 20 years of age, incorrect enrollment other than general anesthesia, postoperative artificial respiration, cancellation of surgery after induction of anesthesia, lack of consciousness after anesthesia, reoperation within 24 hours after anesthesia, insufficient data due to follow-up shorter than 24 hours, and maintenance with a combination of propofol and remimazolam.

Design outcomes

Primary

Measure	Time frame
incidence of postoperative nausea and vomiting	—

Contacts

Public ContactYuji Suzuki

Department of Anesthesiology and Intensive Care Medicine, Hamamatsu University School of Medicine

suzukiy@hama-med.ac.jp+81-534352738

Outcome results